T8995 |
NCGC00262650
|
344359-25-7
|
99.23%
|
|
NCGC00262650 is an inhibitor of AMA1-RON2 interaction and c-Src tyrosine kinase activity.
|
T2070 |
Agerafenib
|
1188910-76-0
|
99.23%
|
|
Agerafenib (CEP32496) is a highly potent inhibitor of BRAF.
|
T13824 |
PP58
|
212391-58-7
|
99.21%
|
|
PP58 is an inhibitor of PDGFR, FGFR and Src family.
|
T2153 |
1-NM-PP1
|
221244-14-0
|
99.2%
|
|
1-NM-PP1 (PP1 Analog II) is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors.
|
T6419 |
BMS-536924
|
468740-43-4
|
99.19%
|
|
BMS-536924 (BMS 536924) is an ATP-competitive IGF-1R/IR inhibitor with IC50 of 100 nM/73 nM, modest activity for Mek, Fak, and Lck with very little activity for ...
|
T2415 |
PP121
|
1092788-83-4
|
99.19%
|
|
PP-121 is a multi-targeted inhibitor of PDGFR (IC50: 2 nM), Hck (IC50: 8 nM), mTOR (IC50: 10 nM), VEGFR2(IC50: 12 nM), Src (IC50: 14 nM) and Abl (IC50: 18 nM) , ...
|
T1985 |
WHI-P154
|
211555-04-3
|
99.19%
|
|
WHI-P154 (Jak3 inhibitor ii) is a potent JAK3 inhibitor.
|
T6077 |
ZM-447439
|
331771-20-1
|
99.11%
|
|
ZM 447439 is a selective and ATP-competitive inhibitor for Aurora A and Aurora B with IC50 of 110 nM and 130 nM, respectively. It is more than 8-fold selective f...
|
T6315 |
MLN8054
|
869363-13-3
|
99.05%
|
|
MLN8054 is a potent and selective Aurora A kinase inhibitor with an IC50 of 4 nM.
|
T6732 |
WYE-687
|
1062161-90-3
|
98.98%
|
|
WYE-687 is an ATP-competitive and selective inhibitor of mTOR with IC50 of 7 nM; blocks mTORC1/pS6K(T389) and mTORC2/P-AKT(S473) but no effect observed on P-AKT(...
|
T17267 |
XL228
|
898280-07-4
|
98.92%
|
|
XL228 is an inhibitor of multi-targeted tyrosine kinase (IC50s: 5, 3.1, 1.6, 6.1, 2 nM for Bcr-Abl, Aurora A, IGF-1R, Src, and Lyn, respectively).
|
T23176 |
PP 3
|
5334-30-5
|
98.92%
|
|
PP 3 is a Negative control for the Src kinase inhibitor PP 2
|
T78605 |
CpCDPK1/TgCDPK1-IN-1
|
1092788-23-2
|
98.71%
|
|
CpCDPK1/TgCDPK1-IN-1 is a potent dual inhibitor of CpCDPK1 and TgCDPK1, inhibits Abl and Src, and has antiparasitic activity for the study of Toxoplasma infectio...
|
T6982 |
SGI-7079
|
1239875-86-5
|
98.7%
|
|
SGI-7079 is a new selective Axl inhibitor. SGI-7079 can be a dose-dependent manner inhibited growth of tumors. It is also a potential therapeutic target for EGFR...
|
T37603L |
Osteogenic Growth Peptide (10-14) acetate
|
|
98.69%
|
|
Osteogenic Growth Peptide (10-14) acetate (Osteogenic Growth Peptide) is a Src inhibitor and an effective mitogen and stimulator of osteogenesis and hematopoiesi...
|
T9411 |
KX2-361
|
897016-26-1
|
98.52%
|
|
KX2-361 is a orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma
|
T23128 |
PD180970
|
287204-45-9
|
98.47%
|
|
PD180970 is an inhibitor of Bcr-Abl with IC50s of 5 nM, 0.8 nM and 50 nM for the autophosphorylation of p210Bcr-Abl, Src and Kit. PD180970 can be used in studies...
|
T6594 |
MNS
|
1485-00-3
|
98.45%
|
|
MNS is a tyrosine kinases inhibitor, inhibits Syk, Src, p97 with IC50 of 2.5 μM, 29.3 μM and 1.7 μM, respectively.
|
T2327 |
Pelitinib
|
257933-82-7
|
98.37%
|
|
Pelitinib (EKB-569) (EKB-569) is an effective irreversible EGFR inhibitor (IC50: 38.5 nM).
|
T6350 |
CHIR-124
|
405168-58-3
|
98.35%
|
|
CHIR-124 is an effective Chk1 inhibitor (IC50: 0.3 nM). It has 2, 000-fold selectivity against Chk2, 500- to 5, 000-fold less activity against Cdc2 and CDK2/4.
|